SCHEMBL3368704

SCHEMBL3368704

Bc1cccc2c(Cl)nccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.55
MAPT P10636 4/20 0.55
CYP3A4 P08684 3/20 0.55
MAPK1 P28482 3/20 0.55
APEX1 P27695 1/20 0.55
PMP22 Q01453 1/20 0.55
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
NR4A2 P43354 1/20 0.37
CYP1A2 P05177 3/20 0.33
CYP2A6 P11509 1/20 0.33
KDM4E B2RXH2 4/20 0.33
MEN1 O00255 4/20 0.33
ALDH1A1 P00352 4/20 0.33
KMT2A Q03164 4/20 0.33
TDP1 Q9NUW8 4/20 0.33
SMN1; SMN2 Q16637 3/20 0.32
ALOX15 P16050 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12266517 0.81 LMNA (0.60) LMNAMAPTCYP3A4MAPK1APEX1
SCHEMBL1315786 0.80 CYP1A2 (0.59) LMNAMAPTCYP3A4MAPK1APEX1
SCHEMBL30892029 0.80 CYP1A2 (0.59) LMNAMAPTCYP3A4MAPK1APEX1
Hydrochloric Acid SCHEMBL6999839 0.78 CYP1A2 (0.56) LMNAMAPTCYP3A4MAPK1APEX1
SCHEMBL5663372 0.77 MAPT (0.53) LMNAMAPTCYP3A4MAPK1APEX1
SCHEMBL1536453 0.77 CYP2A6 (0.54) LMNAMAPTCYP3A4MAPK1APEX1
SCHEMBL2380637 0.77 CYP3A4 (0.54) LMNAMAPTCYP3A4MAPK1APEX1
SCHEMBL31339851 0.77 CYP3A4 (0.54) LMNAMAPTCYP3A4MAPK1APEX1
SCHEMBL1315767 0.77 MAPT (0.53) LMNAMAPTCYP3A4MAPK1APEX1
SCHEMBL1134001 0.77 MAPT (0.53) LMNAMAPTCYP3A4MAPK1APEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012002577-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF 富士フイルム株式会社 (JP) 2012-01-05 WO disclosed